Skip to content

Twist Bioscience Corporation TWST Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax at other companies

Popular logo
PopularBPOP
-$33.1M-120%
Popular logo
PopularBPOP
-$25.26M-118%
Cavco Industries logo
Cavco IndustriesCVCO
$6K-81.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$5.6M-444%
Popular logo
PopularBPOP
$7.84M+130%
RBC Bearings logo
RBC BearingsRBC
$400K

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's other comprehensive income unrealized holding gain loss on securities arising during period net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
Twist Bioscience Corporation (TWST) reported other comprehensive income unrealized holding gain loss on securities arising during period net of tax of -$85K in Q1 2026.
How has Twist Bioscience Corporation's other comprehensive income unrealized holding gain loss on securities arising during period net of tax changed year-over-year?
Twist Bioscience Corporation's other comprehensive income unrealized holding gain loss on securities arising during period net of tax decreased by 383.3% year-over-year, from $30K to -$85K.
What is the long-term trend for Twist Bioscience Corporation's other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
Over 3 years (2021 to 2024), Twist Bioscience Corporation's other comprehensive income unrealized holding gain loss on securities arising during period net of tax has grown at a 143.8% compound annual growth rate (CAGR), from -$14K to $203K.
What does other comprehensive income unrealized holding gain loss on securities arising during period net of tax mean?
This metric tracks the change in the fair value of investment securities held by the company that have not yet been sold. It reflects the unrealized appreciation or depreciation of the investment portfolio due to market price fluctuations. This figure is a component of other comprehensive income and highlights the impact of market volatility on the company's non-operating assets.